Discontinuation or reduction of sulfonylureas and insulin should occur with careful monitoring by the primary care or provider, as appropriate, for individuals with type 2 diabetes interested in a ketogenic diet [293, 294]. Here, INS is linked to type 2 diabetes mellitus.